Farr Miller & Washington’s Celgene Corp CELG Stock Holding History

Farr Miller & Washington’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-83,358	Closed	-$7.16M	–	153
2014 Q2	$7.16M	Buy	83,358 +852	+1%	+$64.8K	0.92%	37
2014 Q1	$5.76M	Sell	82,506 -3,914	-5%	-$310K	0.79%	36
2013 Q4	$7.3M	Buy	86,420 +2,428	+3%	+$192K	1.02%	35
2013 Q3	$6.47M	Sell	83,992 -870	-1%	-$61K	1.03%	35
2013 Q2	$4.96M	Buy	+84,862	New	+$5.11M	0.81%	36

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Farr Miller & Washington's CELG Position: Q3 2014 in Review

Farr Miller & Washington sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 83,358 shares — an estimated $7.16M sold.

Farr Miller & Washington first reported a position in CELG in Q2 2013 and held it in 5 quarters. The position peaked at $7.3M in Q4 2013. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

Farr Miller & Washington reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
Farr Miller & Washington sold 83,358 Celgene Corp shares in Q3 2014, an estimated $7.16M.
Farr Miller & Washington first reported a position in Celgene Corp in Q2 2013 and held it in 5 quarters.
Farr Miller & Washington's Celgene Corp position peaked at $7.3M in Q4 2013.
1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Farr Miller & Washington's 13F filing for Q3 2014, filed 13 Nov 2014.